X

XBIT

XBIT

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
100%Bullish
Buy/Sell Ratio100% buys
BearishBullish
XBIT Live QuoteReal-time
$1.73
$0.24(-12.18%)1M
Day Range$1.61 – $1.81
Open$1.68
Previous Close$1.68
Volume140.2K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$51.22M
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-1.43
Price to Book0.4
Dividend Yield0.65%
Beta (Volatility)0.74
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $1.73 (11%)
Low: $1.61High: $2.73
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$18.00-88.0% upside

Insider Buys

1

$143K

Insider Sales

0

$0

Total Volume

$143K

1 transactions

Net Activity

+$143K

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
65CONFIDENCE

Sentiment Rating

Moderate Accumulation

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
S
1

Simard John

Dir, 10%

1 buys0 sells

$143K total

Trading History
XBIT insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 3, 2026

2 weeks ago

Simard John

Dir, 10%

Director
Buy70.0K$2.05$143K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
XBIT Buy Conviction100%
Industry Rank#452 of 569
Volume Contribution0.0%
Total Industry Activity$16.52B

XBIT has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%. XBIT ranks #452 in insider activity out of 569 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for XBIT

Over the last 90 days, corporate insiders at XBIT (XBIT) engaged in a total of 1 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 0 were sales. The total volume of insider trading reached $143K.

The net insider activity for XBIT shows a net buying bias of $143K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Purchase by Simard John (Dir, 10%), who traded 70.0K shares valued at $143K on Nov 3, 2026.

Live Market News & Developments
Aggregated real-time headlines for XBIT (XBIT)
6 updates

MEDP,RS,R,AIR,TTMI,BNY,ACN,XBIT,HXL | Stock Prices | Quote Comparison - Yahoo Finance

Yahoo! Finance Canada5d ago

A reported 2.57M-share stake in XBiotech (XBIT) includes shares tied to stock options.

Stock Titan2d ago

symbol__ Stock Quote Price and Forecast

CNN1045d ago

XBiotech Q3 2026 Earnings Results and Report

MarketBeat8d ago

A 10% owner buys 70,000 XBiotech (XBIT) shares at $2.0487 each.

Stock Titan7d ago

XBIT 8-K & SEC Filings

Yahoo Finance25d ago

FAQs About XBIT Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for XBIT.

Based on SEC Form 4 disclosures, the Insider Confidence Score for XBIT is currently 65/100, which reflects a moderate accumulation bias. This calculation accounts for a total of 1 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for XBIT is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.